Skip to main content

Biotech ETFs Muddled Despite Amgen Strength

Biotechnology sector-specific exchange traded funds were flat after Amgen (NasdaqGS: AMGN) provided a mixed earnings report but announced that it will return value to investors through greater share buybacks. On Tuesday, the Invesco Nasdaq Biotechnology ETF (IBBQ) was down 0.1%, the iShares...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.